|
|
|
Featured Book
"NH&WL may be the best non-technical book on diet ever written"
Joel Kauffman, PhD, Professor Emeritus, University of the Sciences, Philadelphia, PA |
Low cholesterol and Alzheimer's disease
Alzheimer’s disease makes up 55% of dementia cases in the UK, according to the Alzheimer’s Society and over 800,000 people in the UK currently suffer the affliction.
It is argued by some that the recent growth in numbers of people succumbing to Alzheimer’s disease may be because it is a disease of the elderly and people are living longer. But that theory doesn’t stand up to scrutiny as Alzheimer’s is increasingly seen in younger people. It is also seen in people with other conditions known to be caused by an incorrect ‘healthy’ diet such as diabetes; and the number of people with Alzheimer’s has more than doubled since 1980. ‘It is not entirely surprising that lower cholesterol levels were associated with moderately lower levels of cognitive function, given [that] cholesterol is important in brain function.’And Henry Lorin in his book, Alzheimer’s Solved, shows that low cholesterol level is the main cause of Alzheimer's disease.[4] In November 2007, another study looked at the effects of taking statins on cognitive function and dementure. What the study found was that the: "Initial use of statins resulted in less cognitive decline in individuals, but continued use of a statin resulted in more cognitive decline."(emphasis added)At first sight, this looks confusing. But this new study actually confirms the role of low cholesterol in Alzheimer's disease and in cognitive decline generally. And this is why: Having a high cholesterol is associated with having good cognitive function and with being on a statin. Hence, just after the beginning of statin therapy, these people will still show a relatively good cognitive function. If they continue with the statins, however, the detrimental effects of lower cholesterol on brain function will progressively show up. This is exactly the pattern this study shows. And this is why those who started taking statins, then stopped, were in a better state than those who continued to take them. In view of all this evidence, why on earth is the government so keen to get everyone on cholesterol-lowering drugs? References 1. Max Bürger. Altern und Krankheit als Problem der Biomorphose. 3rd Ed, Georg Thieme, Leipzig, 1957. 2. Corrigan FM, et al. Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's Type II: Effects on lipids. J Nutr Med 1991; 2: 265-71. 3. Elias PK, et al. Serum Cholesterol and Cognitive Performance in the Framingham Heart Study. Psychosom Med 2005; 67:24–30. 4. Lorin, Henry. Alzheimer's Solved. BookSurge Publishing, 2006. 5. Szwast SJ, Hendrie HC, Lane KA, et al. Association of statin use with cognitive decline in elderly African Americans. Neurology 2007; 69: 1873-1880 |
MENU
Home page Contact us Cholesterol What is cholesterol? LDL and HDL explained The dangers of low cholesterol The benefits of high cholesterol Other sterols Cholesterol-lowering drugs Statins Other drugs Causes of Heart Disease High cholesterol Oxidised LDL Dietary saturated fat Inflammation Infections 'Healthy' diet Insulin Other possible causes |